Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 5Recruiting 3Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 4Breast 3Head & Neck 2Thoracic 1Sarcoma 1

Conditions

Thyroid Neoplasms 1Thyroid Diseases 1Parathyroid Diseases 1Neovascularization, Pathologic 1Hypoparathyroidism 1Adenoma 1

Interventions

Cisplatin 57pembrolizumab 54Cetuximab 43Radiotherapy 35Docetaxel 21Radiotherapy, Intensity-Modulated 20Paclitaxel 19Nivolumab 18Fluorouracil 18Carboplatin 17Radiation 14Radiosurgery 9Magnetic Resonance Spectroscopy 8Gemcitabine 8Everolimus 8Biopsy 8Surgical Procedures, Operative 7Oxaliplatin 7Cyclophosphamide 7durvalumab 6avelumab 6Erlotinib Hydrochloride 6Capecitabine 6spartalizumab 5epacadostat 5Surveys and Questionnaires 5Platinum 5Immunoglobulin G 5Gefitinib 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Indocyanine Green × Head & Neck × Clear all
NCT06169735 2026-05-06

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

University of Alabama at Birmingham

Phase 4 Terminated
417 enrolled
Head & Neck

Adenoma, Parathyroid Diseases

NCT05328076 2024-07-05

ANGIO_PARA

IRCCS San Raffaele

Terminated
22 enrolled
Head & Neck

Hypoparathyroidism, Neovascularization, Pathologic, Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡